** Drugmaker Fennec Pharmaceuticals' FENC.O shares down 11.7% at $6.07
** Co posts quarterly net loss of 6 cents per share compared to analysts' estimate of profit of 17 cents per share, according to data compiled by LSEG
** Co also reports fourth-quarter product sales of $7.93 million, missing analysts' estimate of $16.72 million
** Up to last close, FENC has fallen 28.4% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。